Astra Zeneca in $35 m TB drug centre plan
Anglo-Swedish drugs maker AstraZeneca Plc said on Friday it would invest $35 million over five years in a TB drug discovery centre in India, and viewed India as a prospective base for clinical
Anglo-Swedish drugs maker AstraZeneca Plc said on Friday it would invest $35 million over five years in a TB drug discovery centre in India, and viewed India as a prospective base for clinical